We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Merck asked the court to rule that Accord’s generic infringes on the patent and to order that FDA not approve the planned product until after the patent’s expiration in 2026. Read More
Unapproved CBD products have not been evaluated for proper dosage, potential interactions with other FDA-approved drugs, or side effects, and the manufacturing process of unapproved CBD products has not been subjected to FDA review, she said. Read More
Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and ranking member Ron Wyden (D-Ore.) have updated their bipartisan drug pricing legislation with provisions to reduce out-of-pocket expenses — and President Trump has said he would sign it into law. Read More
Four high-ranking House Republicans introduced drug pricing legislation Monday designed to replace House Speaker Nancy Pelosi’s H.R. 3, a bill they dismissed as one-sided and doomed to fail. Read More